Non-accredited medical practitioners
Up to 30 patients
- 20 buprenorphine preparation patients;
- 10 low-risk, methadone patients transferred to your care;
- Cannot initiate patients on methadone.
An introductory module for health professionals interested in learning more about the of core concepts of NSW Opioid Treatment Program and the safe prescribing of opioid pharmacotherapies. Completion of this course is also for those considering to enrol in the the Opioid Treatment Accreditation Course (OTAC).
A comprehensive course on opioid treatment, facilitated by addiction medicine specialists. Aligning with the NSW Clinical Guidelines: Treatment of Opioid Dependence, the OTAC allows medical and nurse practitioners to become an accredited prescriber of opioid pharmacotherapies in NSW.
A online short course for health professionals caring for patients who receive opioid agonist treatment (OAT). Explore the potential impact of treatments and other factors on driving safety. Plus learn about short and long-term fitness to drive, with a focus on sedating medications and OAT.
Depot buprenorphine is a new pharmacotherapy that represents a significant development in the model of care for patients with opioid dependence. This short course is designed to support prescribers, and other health professionals, in NSW in providing this treatment in a safe and effective manner.
Completing the OTAC, followed by a half-day clinical placement, allows for medical and nurse practitioners to apply for accreditation with the NSW Ministry of Health Opioid Pharmacotherapy Subcommittee (OPS).
Non-accredited medical practitioners may still prescribe opioid pharmacotherapies for opioid dependence in a limited capacity.
For more information, refer to the Placements and Accreditation page.